Details for New Drug Application (NDA): 209717
✉ Email this page to a colleague
The generic ingredient in ATAZANAVIR SULFATE is atazanavir sulfate. There are twenty-five drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the atazanavir sulfate profile page.
Summary for 209717
Tradename: | ATAZANAVIR SULFATE |
Applicant: | Amneal |
Ingredient: | atazanavir sulfate |
Patents: | 0 |
Suppliers and Packaging for NDA: 209717
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ATAZANAVIR SULFATE | atazanavir sulfate | CAPSULE;ORAL | 209717 | ANDA | Amneal Pharmaceuticals NY LLC | 69238-1135 | 69238-1135-6 | 60 CAPSULE in 1 BOTTLE (69238-1135-6) |
ATAZANAVIR SULFATE | atazanavir sulfate | CAPSULE;ORAL | 209717 | ANDA | Amneal Pharmaceuticals NY LLC | 69238-1136 | 69238-1136-6 | 60 CAPSULE in 1 BOTTLE (69238-1136-6) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 100MG BASE | ||||
Approval Date: | Jun 1, 2020 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 150MG BASE | ||||
Approval Date: | Jun 1, 2020 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 200MG BASE | ||||
Approval Date: | Jun 1, 2020 | TE: | RLD: | No |
Complete Access Available with Subscription